Teva Pharmaceutical Industries (TEVA) Earnings Analysis
Teva Pharmaceutical Industries (TEVA) next reports earnings on 2026-07-29, consensus EPS 0.04772 USD. Last quarter (2026-04-29) it beat with EPS 0.53 USD vs 0.5 USD est (+6%). It has beaten estimates in 3/3 recent quarters (100%). Trailing P/E 22.49.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does TEVA next report earnings?
| Next earnings date | 2026-07-29 |
|---|---|
| Consensus EPS estimate | 0.04772 USD |
| Revenue estimate | 4.04B |
TEVA earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-04-29 | 0.53 USD | 0.5 USD | +6% | Beat |
| 2026-01-28 | 0.96 USD | 0.65 USD | +47.7% | Beat |
| 2025-01-29 | 0.71 USD | 0.69 USD | +2.9% | Beat |
Beat rate: 3/3 (100%) over reported quarters with consensus data.
TEVA valuation and analyst view
| Trailing P/E | 22.49 |
|---|---|
| Trailing EPS | 1.362 USD |
| Price / book | 4.32 |
| Dividend yield | 0.00% |
| Market cap | 35.40B |
| Analyst consensus | Buy (21 buy / 21 hold / 4 sell) |
| Avg price target | 41.33 USD |
Related research pages
Frequently asked questions
When is Teva Pharmaceutical Industries (TEVA)'s next earnings date?
Teva Pharmaceutical Industries is next scheduled to report on 2026-07-29, with a consensus EPS estimate of 0.04772 USD and revenue estimate of 4.04B.
Did TEVA beat earnings last quarter?
In its 2026-04-29 report, TEVA posted EPS of 0.53 USD versus a 0.5 USD estimate — a beat of 6%.
What is TEVA's earnings track record?
Over the last 3 reported quarters with consensus data, TEVA beat estimates 3 times (100%).
What is TEVA's current P/E ratio and EPS?
TEVA trades at a trailing P/E of 22.49 on trailing EPS of 1.3623837266435985 USD.
What do analysts rate TEVA?
Analyst consensus is "Buy" across 46 ratings (0 strong buy, 21 buy, 21 hold, 4 sell, 0 strong sell). Average 12-month price target: 41.33 USD.